viruslik
particl
vlp
multisubunit
selfassemblycompet
protein
structur
ident
highli
relat
overal
structur
correspond
nativ
virus
term
vlp
use
describ
number
biolog
object
uncharacter
structur
viral
morpholog
found
biolog
sampl
empti
structur
viral
origin
compos
nucleic
acid
infecti
virus
chemic
genet
introduc
structur
modif
noninfecti
selfassembl
gene
product
result
clone
express
viral
structur
gene
heterolog
host
system
cumul
search
term
viruslik
accept
name
particl
googl
scholar
yield
public
record
approxim
least
public
middl
data
demonstr
continu
increas
interest
scientist
technologist
differ
aspect
vlpbase
technolog
interest
new
vlp
larg
inspir
success
develop
introduct
hepat
b
viru
hbv
surfac
antigen
human
papilloma
viru
hpv
capsid
protein
commerci
vaccin
hepat
b
hpvinduc
cervic
cancer
respect
recent
sever
vlpbase
vaccin
candid
enter
differ
stage
clinic
investig
aim
develop
vlpbase
vaccin
medic
veterinari
purpos
near
futur
result
numer
studi
suggest
highimmun
responsestimul
activ
vlp
demonstr
b
cell
activ
hightit
antibodi
product
trigger
surfacedisplay
structur
dens
repeat
amino
acid
aa
motif
vlp
addit
nanometers
vlp
taken
antigenpres
cell
degrad
ultim
lead
cell
activ
moreov
due
symmetr
highli
repetit
aa
structur
vlp
capabl
induc
strong
humor
cellular
immun
respons
even
absenc
frequent
use
adjuv
vlp
great
potenti
number
applic
addit
vaccin
treatment
mani
hereditari
acquir
genet
disord
differ
gene
therapi
tool
one
import
challeng
address
progress
nanotechnolog
comparison
differ
nanocontain
suggest
icosahedr
filament
lipidenvelop
viruslik
vector
promis
gene
carrier
current
success
gene
therapi
larg
base
viral
vector
synthet
liposom
although
number
limit
restrict
packag
capac
product
difficulti
undesir
immunolog
properti
howev
due
construct
flexibl
vlp
engin
overcom
disadvantag
includ
use
chemic
modif
reduc
unwant
immunolog
respons
repeat
use
addit
potenti
applic
vlp
vaccin
gene
therapi
tool
particular
interest
recent
paid
develop
new
nanomateri
compos
differ
virus
vlp
new
area
biotechnolog
call
bionanotechnolog
repres
broad
multidisciplinari
approach
employ
concept
methodolog
biolog
chemistri
physic
engin
new
nanomateri
virus
vlp
possess
sever
advantag
product
produc
chemic
synthesi
includ
size
rang
nm
avail
highresolut
threedimension
model
structur
construct
flexibl
chemic
molecular
biolog
techniqu
high
product
yield
natur
andor
heterolog
host
structur
uniform
type
viru
vlp
narrowli
vlp
also
defin
replicationincompet
macromolecular
protein
assembl
consist
one
sever
structur
protein
differ
virus
obtain
recombin
organ
via
express
correspond
clone
gene
review
summar
publicli
avail
data
vlp
recombin
sourc
discuss
main
principl
method
use
construct
character
macromolecular
assembl
case
exampl
experi
use
nativ
viral
structur
protein
sourc
vlp
includ
demonstr
remark
idea
techniqu
use
obtain
character
vlp
inform
replicationcompet
vlp
synthet
nanoparticl
viruslik
properti
found
review
articl
sinc
begin
vlp
origin
microbi
plant
insect
mammalian
virus
construct
character
aim
studi
use
particl
varieti
purpos
basic
viru
assembl
structur
studi
product
commerci
human
anim
vaccin
exampl
vlp
differ
viru
famili
group
accord
structur
encapsid
nucleic
acid
summar
tabl
list
publish
vlp
use
data
analysi
review
along
express
system
properti
applic
exampl
found
supplement
tabl
supplement
data
group
accord
host
nativ
virus
isol
bacteri
plant
mammalian
vlp
histor
first
recombin
vlp
obtain
synthes
clone
coat
protein
cp
gene
hbv
core
antigen
hbcag
hbv
surfac
antigen
hbsag
tobacco
mosaic
viru
tmv
first
visual
recombin
vlp
use
electron
microscopi
publish
demonstr
hbcag
vlp
indistinguish
core
shell
isol
hbvinfect
liver
first
exampl
establish
sever
import
ground
rule
construct
recombin
vlp
construct
recombin
vlp
larg
base
sever
year
even
ten
year
basic
research
correspond
viru
ii
necessari
code
nucleic
acid
carrier
coat
protein
foreign
function
peptid
obtain
synthet
align
oligonucleotid
iii
foreign
peptid
insert
ad
virusbas
carrier
molecul
without
influenc
selfassembl
iv
vlp
obtain
heterolog
host
v
newli
construct
recombin
vlp
signific
advantag
nativ
virus
avail
nearli
unlimit
amount
similar
even
better
function
properti
first
stage
vlp
construct
clone
necessari
structur
gene
clinic
veterinari
specimen
well
environment
sampl
infect
plant
microorgan
cell
typic
serv
sourc
gene
take
account
fact
nucleotid
sequenc
record
found
search
entrez
site
life
scienc
search
engin
ncbi
use
keyword
viru
sequenc
viral
structur
protein
interest
like
found
databas
case
sequenc
suffici
use
oligonucleotid
gene
synthesi
absenc
infect
materi
note
gene
synthesi
permit
inclus
typic
aa
codon
heterolog
host
target
gene
enhanc
express
level
target
protein
altern
least
case
e
coli
usag
special
host
strain
synthes
rare
aa
codonrecogn
trna
stimul
effici
synthesi
vlp
origin
sequenc
typic
known
vlp
deriv
virus
well
character
least
level
fulllength
nucleotid
sequenc
genom
organ
due
vast
amount
inform
avail
differ
vlp
possibl
analyz
detail
clone
viral
structur
gene
case
tabl
contain
list
structur
gene
viru
famili
express
gene
necessari
construct
respect
vlp
exampl
citat
bacteri
system
mostli
base
wellcharacter
commerci
escherichia
coli
strain
express
vector
despit
disadvantag
inabl
produc
recombin
protein
posttransl
modif
inabl
gener
proper
disulfid
bond
protein
solubl
problem
presenc
endotoxin
prepar
recombin
protein
e
coli
system
gener
accept
technolog
satisfi
mani
research
industri
requir
wide
use
vlp
product
success
vlp
product
use
e
coli
like
achiev
case
target
vlp
contain
one
coat
protein
cp
see
tabl
solubl
cell
cultiv
howev
recombin
protein
especi
origin
eukaryot
host
often
insolubl
e
coli
system
demonstr
parvoviru
ccmv
cmv
plant
virus
viral
cp
also
effici
produc
form
insolubl
inclus
bodi
purifi
denatur
condit
refold
selfassembl
moreov
selfassembl
vlp
e
coli
cell
initi
simultan
coexpress
specif
rna
structur
eg
origin
assembl
cp
gene
howev
simpl
chang
cultiv
condit
solv
problem
inclus
bodi
lowtemperatur
cultiv
rather
atyp
e
coli
may
stimul
format
solubl
vlp
shown
case
densoviru
ihhnv
potyviru
pvi
addit
sever
factor
resist
marker
express
plasmid
composit
cultiv
medium
influenc
assembl
vlp
demonstr
bacteriophag
vlp
e
coli
cell
also
use
complic
product
vlp
requir
one
type
structur
protein
format
clone
express
e
coli
avibirnaviru
ibdv
polyprotein
gene
tabl
polyprotein
cotransl
autoprocess
proteas
activ
enabl
format
immunolog
activ
vlp
bacteri
cell
howev
shown
plant
viru
mrfv
inclus
correspond
proteas
gene
express
cassett
alway
necessari
synthesi
vlp
achiev
simpl
coexpress
two
engin
cp
gene
singl
express
vector
anoth
approach
use
achiev
higher
express
level
solubl
involv
usag
differ
fusion
protein
system
papillomaviru
hpv
protein
obtain
recombin
e
coli
cell
form
glutathionestransferas
gst
fusion
protein
vlp
assembl
protein
complet
gst
section
remov
thrombin
qualiti
result
particl
suffici
obtain
crystal
subsequ
xray
crystallograph
analysi
result
construct
model
icosahedr
hpv
particl
fusion
protein
strategi
also
success
exploit
polyomaviru
mupyv
picornaviru
fmdv
vlp
ntermin
part
cp
locat
vlp
surfac
ntermin
ad
short
peptid
histag
small
protein
epitop
influenc
particl
format
directli
introduc
vlp
structur
without
proteolyt
cleavag
reassembl
vitro
prokaryot
organ
also
use
vlp
product
exampl
lactobacillu
use
product
hpv
protein
gener
edibl
vaccin
candid
pseudomona
use
improv
low
solubl
cp
ccmv
sinc
first
success
experi
hbv
surfac
protein
led
product
commerci
prophylact
vaccin
hepat
b
use
hpv
vlp
vaccin
cervic
cancer
differ
yeast
system
use
construct
numer
vlp
includ
express
viral
structur
gene
bacteri
yeast
plant
mammalian
origin
see
also
supplement
tabl
yeast
express
system
especi
base
pichia
hansenula
strain
complic
e
coli
express
system
point
view
construct
yeast
shuttlevector
first
prepar
bacteria
introduc
yeast
cell
plasmid
vector
select
obtain
stabl
yeast
recombin
genomeintegr
transgen
compar
studi
yeast
express
system
reveal
effici
pichia
product
rna
bacteriophag
vlp
howev
product
result
approxim
yield
obtain
e
coli
observ
vlp
yeast
system
also
use
packag
function
heterolog
mrna
bacteriophag
vlp
simultan
synthesi
cp
mrna
model
protein
accomplish
express
vector
case
design
express
cassett
requir
presenc
special
packag
rna
sequenc
found
nativ
genom
howev
packag
signal
alway
necessari
format
vlp
yeast
cell
saccharomyc
express
system
produc
solubl
ccmv
vlp
contain
mostli
hostderiv
rna
contrari
e
colibas
express
system
cp
form
inclus
bodi
anoth
advantag
yeast
system
possibl
introduc
posttransl
modif
glycosyl
phosphoryl
vlp
structur
shown
hepat
b
vlp
similar
vlp
recombin
bacteria
success
multigen
express
system
also
construct
yeast
express
three
rotaviru
structur
gene
tabl
singl
plasmid
vector
lead
format
triplelay
vlp
cerevisia
cell
howev
case
envelop
virus
cerevisia
cell
support
multimer
gag
protein
vlp
particl
bud
suggest
yeast
contain
necessari
host
factor
import
note
vlp
format
alway
take
place
cultiv
process
yeast
cell
experi
hbsag
pichia
suggest
selfassembl
vlp
complet
purif
target
product
insect
cellbas
express
system
wide
use
vlp
product
laboratori
industri
scale
due
number
advantag
fast
growth
rate
anim
productfre
media
capac
largescal
cultiv
abil
posttransl
modifi
recombin
protein
similarli
mammalian
cell
insect
cell
line
deriv
trichoplusia
ni
use
product
commerci
hpv
vaccin
addit
least
addit
vlp
isol
recombin
insect
cell
differ
stage
develop
vaccin
candid
express
foreign
viral
protein
gene
insect
cell
construct
vector
base
modifi
baculovirus
necessari
obtain
vlp
contain
one
structur
protein
insect
cell
line
infect
multipl
differ
monocistron
baculovirus
coinfect
singl
polycistron
baculoviru
coexpress
coinfect
strategi
accept
approach
allow
manipul
rel
express
level
correspond
structur
protein
moreov
strategi
allow
identif
protein
necessari
vlp
format
use
coinfect
methodolog
differ
protein
shown
simultan
express
selfassembl
vlp
within
cell
demonstr
herpesviru
hsv
coexpress
strategi
also
shown
effect
construct
vlp
includ
deriv
influenza
use
tricistron
baculoviru
triplic
polyhedron
promot
even
quadrupol
baculoviru
three
polyhedrin
one
promot
construct
vlp
virus
polyprotein
genom
organ
accomplish
clone
whole
polyprotein
gene
baculoviru
vector
polyprotein
strategi
success
use
case
alphaviru
sav
concert
action
alphaviru
proteas
polyprotein
hostderiv
proteas
atyp
lowcel
cultur
cultiv
temperatur
crucial
factor
format
matur
vlp
similar
result
use
polyprotein
cleavag
approach
obtain
plant
viru
cpmv
demonstr
experi
vlp
polyprotein
strategi
effici
term
vlp
yield
coinfect
method
interestingli
baculovirusbas
vector
also
use
whole
insect
larva
includ
silkworm
larva
cheaper
altern
produc
vlp
recent
baculovirussilkworm
multigen
express
system
insur
simultan
express
six
differ
transgen
singl
recombin
baculoviru
initi
attempt
gener
vlp
whole
transgen
natur
plant
differ
transient
express
vector
tightli
bound
idea
edibl
vaccin
howev
modern
medic
concept
requir
precis
formul
vaccin
product
supervis
administr
insur
reproduc
effect
made
inject
vaccin
accept
despit
revis
concept
plant
system
remain
costeffect
scalabl
altern
product
differ
medicin
protein
includ
vaccin
recent
develop
norwalk
vlp
manufactur
good
manufactur
practic
gmp
condit
subsequ
clinic
trial
result
first
human
trial
edibl
vaccin
continu
support
idea
vlp
plant
sourc
use
vaccin
suggest
necess
research
area
principl
construct
vlp
differ
plant
express
system
success
product
vlp
plant
selfassembl
numer
viral
structur
protein
plant
host
extens
discuss
sever
review
articl
exampl
one
effect
plant
express
system
base
agrobacteriummedi
transfer
tobamovirusderiv
express
vector
whole
plant
cell
result
yield
g
recombin
vlp
per
kg
leaf
biomass
mention
plant
host
infect
nativ
virus
serv
sourc
assemblycompet
viral
structur
protein
construct
new
nanomateri
two
decad
use
mammalian
cell
cultur
sourc
commerci
therapeut
protein
develop
take
advantag
product
authent
correct
glycosyl
pattern
obtain
system
half
recombin
protein
pharmaceut
industri
produc
differ
mammalian
cell
line
despit
complex
construct
practic
applic
mammalian
cell
line
system
wide
use
vlp
product
basic
experi
industri
scale
aim
construct
vaccin
candid
gene
therapi
agent
differ
mammalian
cell
especi
effici
host
construct
complex
envelop
virus
includ
influenza
virus
stabl
mammalian
cell
line
express
four
influenza
structur
protein
construct
possibl
creat
hybrid
vlp
contain
matrix
protein
one
influenza
type
surfac
glycoprotein
anoth
type
system
would
allow
gener
correctli
glycosyl
vlp
similar
size
nativ
virus
encapsid
host
cellular
protein
highimmunolog
activ
complic
system
develop
obtain
vlp
shown
influenza
virus
cell
line
infect
recombin
vaccinia
viru
vector
express
polymeras
transfect
bacteri
plasmid
contain
cdna
ten
influenza
viru
protein
abl
produc
vlp
moreov
model
protein
mrna
cdna
transcript
rescu
influenza
vlp
polyprotein
strategi
describ
also
use
mammalian
cell
polyprotein
cdna
encod
structur
protein
alphaviru
chikv
clone
eukaryot
express
vector
introduc
human
cell
line
result
cell
produc
chikv
vlp
demonstr
immunolog
electron
microscopi
analys
interestingli
experi
demonstr
chikv
vlp
abl
elicit
stronger
antibodi
respons
correspond
dna
vaccin
crude
cell
extract
use
tool
protein
synthesi
year
past
cellfre
protein
synthesi
cfp
mostli
use
basic
studi
transcript
translat
mechan
well
rapid
evalu
differ
express
system
recent
year
develop
cfp
reach
stage
independ
express
system
potenti
industri
signific
cfp
system
base
e
coli
wheat
germ
insect
cell
rabbit
reticulocyt
commerci
avail
popular
e
colideriv
cfp
due
simpl
prepar
extract
compar
high
yield
desir
protein
recent
synthesi
rna
bacteriophag
hbv
corederiv
vlp
demonstr
use
e
colibas
cfp
technolog
case
vlp
cfp
allow
incorpor
protein
toxic
live
cell
wherea
product
hbcag
vlp
chosen
cellfre
system
provid
consider
stabil
particl
introduct
disulfid
bond
notabl
yield
vlp
almost
mgml
effici
vlp
assembl
exce
case
hbcag
proof
concept
experi
use
wellestablish
vlp
model
suggest
cfp
also
use
complic
case
especi
express
viral
structur
protein
gene
toxic
live
cell
condit
tradit
system
allow
product
vlp
desir
properti
eg
incorpor
unnatur
amino
acid
necessari
insur
construct
synthes
vlp
remain
intact
intend
downstream
applic
select
correct
purif
scheme
utmost
import
vlp
purif
character
larg
base
experi
obtain
experi
differ
virus
therefor
initi
condit
develop
purif
protocol
newli
construct
uncharacter
vlp
base
use
correspond
nativ
viru
section
import
method
current
use
vlp
purif
identif
character
review
vlp
industri
product
two
decad
gener
principl
vlp
purif
well
known
includ
follow
step
lysi
cell
transfer
synthes
vlp
solut
ii
clarif
process
insur
remov
cell
debri
larg
aggreg
iii
concentr
step
iv
polish
step
remov
residu
host
target
productderiv
impur
cell
lysi
import
step
vlp
purif
howev
mani
mammalian
insect
cell
system
insur
secret
vlp
cultur
supernat
cell
lysi
step
alway
necessari
vlp
produc
nonsecret
system
requir
use
suitabl
approach
prepar
cellfre
extract
exampl
simpl
treatment
eukaryot
cell
detergentcontain
solut
suffici
contrast
bacteri
yeast
plant
cell
requir
strong
mechan
treatment
variou
mill
french
press
ultrason
grind
abras
eg
aluminum
oxid
repeat
freezingthaw
cycl
enzymat
treatment
purif
uncharacter
vlp
unknown
stabil
properti
differ
cell
lysi
protocol
extract
buffer
composit
test
identifi
optim
method
preserv
integr
particl
protect
vlp
oxid
host
proteas
purif
process
extract
buffer
often
supplement
reduc
chelat
agent
proteas
inhibitor
addit
nucleas
sometim
ad
stage
reduc
amount
host
nucleic
acid
extract
clarif
lowspe
centrifug
ultrafiltr
vlpcontain
solut
concentr
purifi
number
virus
vlp
stabl
enough
withstand
precipit
ammonium
sulfat
andor
polyethylen
glycol
peg
precipit
significantli
decreas
volum
extract
amount
hostderiv
impur
ultim
result
reduc
number
subsequ
centrifug
chromatographi
purif
step
laboratoryscal
purif
vlp
purif
ultracentrifug
cscl
sucros
gradient
often
suffici
obtain
suitabl
prepar
subsequ
applic
especi
success
round
low
highspe
centrifug
appli
industrialscal
process
use
ultracentrifug
restrict
due
risk
vlp
aggreg
lack
scalabl
enhanc
labor
intens
thu
instead
use
ultracentrifug
necessari
puriti
vlp
often
achiev
special
chromatograph
process
depend
properti
vlp
differ
sizeexclus
ion
exchang
affin
column
use
purif
process
howev
addit
step
treatment
vlp
solut
diatom
earth
column
chromatographi
may
necessari
achiev
desir
vaccinegrad
puriti
level
demonstr
product
hbsag
pichia
purif
scheme
includ
remov
host
target
productderiv
impur
vlp
special
case
improv
function
properti
target
vlp
disassemblyreassembl
stage
necessari
exampl
reassembl
human
papilloma
vlp
exhibit
enhanc
immunoreact
stabil
properti
necessari
emphas
method
allow
identif
vlp
initi
stage
construct
differ
vlp
properti
use
earli
detect
screen
method
partial
overlap
use
purif
applic
peg
ammonium
sulfat
abil
bind
water
molecul
solubl
level
vlp
exceed
use
precipit
highmolecular
vlp
leav
lowmolecular
impur
extract
solut
puriti
precipit
usual
suffici
simpl
downstream
analysi
identifi
vlp
structur
protein
sdspage
agaros
gel
retard
test
proteinnucl
acid
complex
typic
use
vlp
sucros
gradient
sizeexclus
chromatographi
demonstr
highmolecular
state
vlp
altern
precipit
condit
disassembl
particl
vlpcontain
extract
directli
concentr
ultracentrifug
mono
polyclon
antibodi
correspond
nativ
viru
vlp
avail
addit
proof
vlp
format
obtain
use
elisa
western
blot
immun
diffus
test
ouchterloni
doubl
radial
immun
diffus
agaros
electron
microscopi
analysi
necessari
final
visual
proof
new
synthes
vlp
abovement
indirect
test
may
identifi
larg
unstructur
protein
aggreg
vlp
purif
differ
properti
target
vlp
test
demonstr
accord
indent
downstream
applic
valuabl
tool
analysi
vlp
composit
mass
spectrometri
allow
measur
molecular
mass
assembl
protein
techniqu
use
identifi
proteolyt
degrad
posttransl
modifi
protein
vlp
structur
analysi
glycosyl
pattern
mammalian
vlp
lectinbas
glycan
differenti
assay
use
rapid
method
identif
structur
protein
modif
structur
integr
vlp
also
demonstr
trypsin
treatment
presenc
absenc
deterg
capabl
dissoci
vlpform
subunit
differ
vlp
physic
paramet
signific
factor
develop
new
identif
method
applic
vlp
concentr
measur
complic
due
proteinnucl
acid
content
particl
nevertheless
simpl
accur
concentr
measur
base
uv
spectra
avail
plant
viru
bmv
hbcag
vlp
also
applic
virus
vlp
addit
isoelectr
point
measur
capillari
isoelectr
focus
found
use
differenti
vlp
differ
noroviru
genogroup
complic
case
immun
electron
cryomicroscopi
imag
provid
necessari
proof
correct
construct
vlp
immunoelectron
microscopi
use
colloid
gold
conjug
antibodi
wide
use
vlp
research
found
necessari
visual
local
antigen
vlp
surfac
electron
cryomicroscopi
provid
imag
compar
high
resolut
use
number
case
includ
bluetongu
hcv
chikv
vlp
method
also
use
visual
display
foreign
peptid
vlp
surfac
detail
inform
electron
microscopi
addit
exampl
found
review
articl
crystal
subsequ
xray
structur
analysi
usual
appli
resolut
character
vlp
properti
vlp
also
use
case
correspond
nativ
virus
avail
prepar
amount
stepwis
viru
assembl
studi
vlp
mostli
produc
differ
downstream
applic
stabil
recombin
particl
one
signific
issu
anoth
import
reason
perform
stabil
experi
necessari
determin
condit
support
disassembl
particl
subsequ
reassembl
packag
foreign
agent
protein
nucleic
acid
lowmolecular
mass
compound
obtain
data
stabil
purifi
vlp
incub
differ
buffer
solut
andor
elev
temperatur
one
popular
method
demonstr
influenc
incub
condit
vlp
structur
abovement
nativ
agaros
gel
analysi
use
plant
viru
ccmv
rna
bacteriophag
howev
method
applic
vlp
contain
nucleic
acid
dimens
vlp
compat
agaros
gel
analysi
filament
empti
vlp
method
appropri
variou
spectroscop
techniqu
use
norwalk
vlp
detect
appear
lowmolecular
structur
separ
sampl
ultracentrifug
case
noroviru
mechan
stabil
correspond
vlp
test
atom
forc
microscopi
highthroughput
analys
structur
chang
vlp
elev
temperatur
monitor
presenc
syproorang
dye
use
realtim
pcr
system
dna
melt
point
determin
program
case
result
stabil
studi
correct
electron
microscopi
visual
necessari
hybrid
rodlik
vlp
bacteriophag
ga
fr
convent
express
system
insur
product
oxid
vlp
stabil
vlp
consider
enhanc
introduct
disulfid
bridg
crosslink
individu
structur
protein
hydrogen
peroxid
cellfre
system
result
disulfid
bridgescontain
vlp
withstand
temperatur
wherea
reduc
vlp
stabl
temperatur
approxim
simpl
addit
also
enhanc
vlp
stabil
vaccin
formul
studi
known
addit
addit
polysorb
sorbitol
disaccharid
trehalos
effect
prevent
vlp
aggreg
viral
structur
protein
typic
nucleic
acidbind
protein
numer
studi
demonstr
abil
recombin
vlp
bind
encapsid
nucleic
acid
present
host
cell
mrna
transgen
ribosom
andor
transport
rna
case
mrna
clone
gene
found
vlp
dna
microarray
experi
suggest
ccmv
vlp
along
mrna
capabl
encapsid
larg
number
pseudomona
mrna
except
ribosom
rna
abund
cell
rna
found
case
fhv
use
nextgener
sequenc
techniqu
vlp
mostli
encapsid
ribosom
rna
transcript
introduc
baculoviru
express
vector
interestingli
nativ
fhv
virion
also
exhibit
abil
packag
host
rna
although
particl
packag
approxim
total
amount
identifi
rna
secondari
structur
respons
encapsid
process
selex
system
recent
develop
nucleic
acidbind
test
plant
viru
stnv
vlp
round
select
singl
rna
stem
loop
identifi
potenti
vlp
assembl
initi
site
instead
eight
differ
secondari
structur
sntv
genom
partial
correspond
consensu
sequenc
found
selex
method
data
suggest
possibl
mechan
host
nucleic
acid
encapsid
recombin
vlp
transcriptoma
heterolog
host
clone
viral
structur
gene
contain
rna
necessari
secondari
structur
suffici
amount
serv
factor
stimul
even
initi
vlp
format
mani
case
construct
vlp
tightli
bound
aim
obtain
structur
multimer
protein
assembl
specif
properti
subsequ
applic
case
success
construct
vlp
extent
univers
eg
use
differ
purpos
similar
principl
action
highli
import
develop
technolog
platform
section
exampl
vlp
notic
univers
properti
discuss
first
vlp
use
differ
purpos
base
intrins
properti
without
chang
structur
protein
mammalian
vlp
recogn
cell
correspond
organ
abl
deliv
cargo
therapeut
nucleic
acid
protein
recipi
organ
abil
bind
specif
nucleic
acid
common
viral
structur
protein
use
bind
encapsid
neg
charg
substanc
oligonucleotid
biolog
chemic
polym
shown
recombin
hbcag
ccmv
vlp
bind
properti
seem
univers
howev
packag
limit
size
neg
charg
polym
limit
appar
bound
intern
volum
correspond
vlp
avail
posit
charg
aa
vlp
structur
therefor
polyomaviru
jc
vlp
gene
therapi
vector
candid
abl
packag
differ
plasmid
dna
size
exceed
kbp
kbp
cultiv
e
coli
cell
addit
packag
vlp
intrins
properti
surfaceloc
aa
region
serv
target
introduct
variou
function
molecul
two
gener
method
introduc
molecul
carrier
vlp
chemic
coupl
genet
fusion
chemic
coupl
process
method
known
modifi
protein
use
provid
condit
reaction
preserv
structur
integr
vlp
case
surfaceloc
lysin
residu
target
coupl
although
aa
cystein
tyrosin
aspart
glutam
acid
also
modifi
vlp
shown
possess
nearli
univers
properti
chemic
conjug
one
beststudi
vlp
properti
plant
viru
cpmv
vlp
deriv
bacteriophag
valid
coupl
differ
antigen
includ
lowmolecular
substanc
nicotin
whole
protein
aim
obtain
prophylact
therapeut
vaccin
vlp
without
reactiv
aa
surfac
necessari
univers
achiev
target
mutagenesi
shown
case
tmv
incorpor
access
lysin
residu
subsequ
coupl
biotin
moieti
viru
enabl
tight
bind
molecul
recombin
streptavidincontain
model
protein
per
viral
particl
introduct
aa
cystein
vlp
found
use
subsequ
coupl
multival
display
ligand
genet
method
wide
use
introduct
differ
peptid
includ
immunolog
relev
epitop
vlp
structur
addit
introduct
specif
peptid
contribut
broaden
potenti
vlp
applic
recent
heterodimer
coiledcoil
aa
motif
found
use
packag
differ
protein
vlp
interior
without
chemic
coupl
genet
fusion
interact
coiledcoil
motifcontain
ccmv
cp
protein
interest
insur
strong
bind
two
compon
allow
encapsid
molecul
model
protein
insid
nm
ccmv
particl
introduct
whole
protein
vlp
structur
also
achiev
genet
fusion
especi
case
larger
vlp
versatil
system
call
splitcor
recent
develop
hbcag
vlp
split
hbcag
gene
encod
immunodomin
region
two
part
express
fragment
e
coli
retain
abil
vlp
format
system
allow
display
sever
protein
medicin
relev
size
aa
vlp
surfac
split
principl
also
applic
vlp
anoth
interest
develop
made
vlp
suitabl
differ
applic
incorpor
protein
aderiv
domain
particl
structur
domain
known
effect
bind
constant
region
antibodi
molecul
igg
differ
organ
display
domain
particl
surfac
vlp
abl
bind
g
igg
per
g
carrier
offer
simpl
procedur
purif
differ
monoclon
antibodi
vlp
protein
domain
bound
antibodi
also
use
address
deliveri
therapeut
nucleic
acid
specif
cell
sensit
diagnost
agent
exampl
multifunct
vlp
protein
deliveri
found
recent
review
latest
metagenom
evalu
suggest
virologist
use
less
exist
viral
divers
therefor
environment
sampl
repres
inexhaust
sourc
new
viral
structur
gene
new
vlp
defin
properti
construct
howev
construct
process
new
vlp
still
expens
laborintens
use
mammalian
express
system
accept
construct
structur
complic
vlp
particularli
introduct
correct
posttransl
modif
andor
product
vlp
contain
multipl
structur
protein
necessari
confirm
numer
experi
insect
yeast
cell
system
effect
altern
mammalian
host
howev
construct
new
vlp
consid
e
coli
host
first
test
host
lower
cost
requir
shorter
construct
time
due
absenc
gener
applic
rapid
screen
method
ineffici
silico
predict
approach
use
construct
new
modifi
exist
vlp
trial
error
method
subsequ
visual
confirm
electron
microscopi
take
account
advanc
vaccin
develop
vlp
posit
reput
system
academ
industri
commerci
signific
longer
mere
laboratori
curios
howev
field
gene
therapi
nanomateri
potenti
vlp
applic
technolog
base
laboratori
experi
studi
perspect
vlpbase
object
applic
must
continu
demonstr
predict
sustain
cost
effici
technolog
